June 7, 2009

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

June 4, 2009

Just as the FDA is convening an advisory committee hearing (June 9-10) about whether to expand the

Read More
Marketing Trumps Safety: the case of Antipsychotics

May 29, 2009

Sunshine is the great disinfectant! The Wall Street Journal reports that antipsychotic drug prescriptions for children–which the

Read More
Rx for Antipsychotc Drugs for Children Begin To Decelerate_WSJ

May 8, 2009

The unexpected approval of a "me too" dangerous antipsychotic drug that the agency itself had deemed "NOT

Read More
Has the Obama administration already cowered to the demands of Big Pharma?

May 7, 2009

"Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research,

Read More
Title: FDA Approves Antipsychotic With Long History of Failure

April 20, 2009

ALLIANCE FOR HUMAN RESEARCH PROTECTION A catalyst for public debate 142 West End Avenue Suite 28P New

Read More
AHRP Letter to Harvard Re: Dr. Biederman’s Research

April 8, 2009

FDA-AstraZeneca Hearing

March 30, 2009

The State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being

Read More
Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren

February 27, 2009

The lid of another pharmaceutical company’s Pandora Box has been lifted: Lawyers agreed to unseal most AstraZeneca

Read More
AstraZeneca: “Smoke-and-Mirror Job”

November 24, 2008

A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing

Read More
Biederman J & J Risperdal Documents

November 24, 2008

The New York Times reports (below) "Dr. Biederman’s work helped to fuel a 40-fold increase from 1994

Read More
Biederman J & J Risperdal Documents

November 18, 2008

The New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic

Read More
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach

November 30, 2007

                                 ALLIANCE FOR HUMAN RESEARCH PROTECTION   www.ahrp.org 142 West End Avenue, Suite 28P New York, NY

Read More
Letter of Complaint to FDA Commissioner, 2007

February 25, 2007

Evelyn Pringle reports (below) that the group is also supporting Jim Gottstein in his battle with Eli

Read More
Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa